×
×
×
×
×

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
  

Economic Outlook 2024: The Year of Lagged Effects

November 28, 2023

banner-aor-podcast.jpeg

 

The Anatomy of a Recession team of Jeff Schulze and Josh Jamner makes their annual forecasts for the economy and equity markets, discussing why the lagged impacts of the Fed's aggressive monetary tightening cycle should be fully felt in the year ahead and how a second wave of inflation remains a major risk. They also discuss the implications for equities through a volatile economic environment.

Related Perspectives

Tailwinds Forming for Health Care
Podcast: Improved biopharma funding is proving beneficial to CROs and life science tools companies while patent expirations are separating pharmaceuticals.
Gaining Flexibility in Shifting Growth Market
Large Cap Growth 2Q26: We believe benchmark changes, greater portfolio latitude and continued AI infrastructure leadership create a strong setup for the second half.
Narrow Market Full of Overlooked Value
Dividend Strategy 2Q26: With record market concentration despite uncertainty introduced by profound technological change, diversification is paramount.
Large Cap Growth Monthly Update
Large Cap Growth May 2026: Software was a bright spot in May, with several holdings rerating on improving sentiment and solid earnings results.
Large Cap Growth Monthly Update
Large Cap Growth April 2026: A risk-on April provided a measure of confidence in the Strategy’s ability to participate effectively in strong up markets.
More
  • Past performance is no guarantee of future results. Copyright © 2023 ClearBridge Investments. All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information.

  • Performance source: Internal. Benchmark source: Standard & Poor's.

more